Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06007846 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer

StatusRecruiting
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 years later Jul 31, 2026 → Jul 31, 2028
See other at-risk trials from Inova Health Care Services

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Jul 31, 2026 to Jul 31, 2028 Show 4 more changesShow less
    • Study completion pushed from Aug 31, 2026 to Jul 31, 2029
    • Eligibility criteria expanded, about 22 words
    • Site contacts updated at 2 of 2 sites
    • Publications: details revised at 36 of 37 entries
  2. Primary completion date: Jul 31, 2025 to Jul 31, 2026
    • Study completion date: Aug 31, 2025 to Aug 31, 2026
    v4
  3. Primary completion date: Aug 31, 2024 to Jul 31, 2025v3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 1 to 2
    • Start date changed from estimate of Aug 31, 2023 to Jul 31, 2023
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a single-site prospective study to describe efficacy endpoints of single agent memantine in patients with unresectable, locally advanced, or metastatic HCC otherwise not deemed candidates for intensive systemic therapy. In addition to the primary endpoint and multiple secondary efficacy endpoints, we will describe changes in quality of life on treatment over time.
Trial Details
NCT Number NCT06007846
Lead Sponsor Inova Health Care Services
Conditions
(from sponsor)		 Hepatocellular Carcinoma, Cirrhosis
Related terms Carcinoma, Hepatocellular, Fibrosis
Enrollment 12 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov